Point Biopharma Investor Sues For Info On Lilly's $1.4B Buy
A shareholder of Point Biopharma Global Inc. has sued the Indiana radiopharmaceutical company in Delaware's Court of Chancery, seeking to inspect its books and records in connection with its $1.4 billion...To view the full article, register now.
Already a subscriber? Click here to view full article